CompletedPhase 2

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer

United States23 participantsStarted 2007-09

Plain-language summary

The purpose of this study is to determine the progression-free survival of patients with surgically staged, Stage I-II papillary serous, clear cell, or endometrioid carcinomas with high-intermediate risk factors treated by vaginal cuff brachytherapy followed by chemotherapy.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients must have undergone specified complete surgical staging. * Patients must be surgically staged endometrial cancer patients at high-risk for recurrence. * Patients must have adequate bone marrow, renal and hepatic function. Exclusion Criteria: * Patients with recurrent disease. * Patients with GOG performance status of 3 or 4.

What they're measuring

Number of Patients With Progression-free Survival at 2 Years

Timeframe: 2 years

Trial details

NCT IDNCT00542490

SponsorUniversity of Oklahoma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-02

Results submitted2017-04-14

View on ClinicalTrials.gov More Endometrial Cancer trials